Results 41 to 50 of about 1,151 (123)

Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods [PDF]

open access: yes, 2018
The concept that abnormal protein aggregates show prion-like propagation between cells has been considered to explain the onset and progression of many neurodegenerative diseases.
Arai Tetsuaki   +5 more
core   +2 more sources

Bloody big data : ensuring the health of blood donors and transfused patients with health registers [PDF]

open access: yes, 2022
Blood transfusion is widely considered a pillar of modern medicine and is one of the most common medical interventions. A transfusion intimately links two persons and their health through the altruism of blood donors.
Zhao, Jingcheng
core   +1 more source

Cross currents in protein misfolding disorders: interactions and therapy. [PDF]

open access: yes, 2009
Protein Misfolding Disorders (PMDs) are a group of diseases characterized by the accumulation of abnormally folded proteins. Despite the wide range of proteins and tissues involved, PMDs share similar molecular and pathogenic mechanisms.
Green, Kristi M   +2 more
core   +1 more source

Clinical-radiological presentation and natural history of iatrogenic cerebral amyloid angiopathy [PDF]

open access: yes
Background: We aimed to describe neuroimaging features, clinical profiles and long-term outcomes in patients with iatrogenic cerebral amyloid angiopathy (iCAA).Methods: We performed a systematic literature search for case series of iCAA and included ...
Ambler, Gareth   +17 more
core   +4 more sources

Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease:Opportunities for therapy [PDF]

open access: yes, 2023
This editorial summarizes advances from the Clearance of Interstitial Fluid and Cerebrospinal Fluid (CLIC) group, within the Vascular Professional Interest Area (PIA) of the Alzheimer's Association International Society to Advance Alzheimer's Research ...
Agarwal, N   +25 more
core   +2 more sources

Endoplasmic Reticulum Stress: A Novel Target for the Prevention and Treatment of Hypertension and Its Related Diseases

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 23, December 2025.
ABSTRACT Endoplasmic reticulum stress (ERS) emerges as a critical pathophysiological nexus in hypertension and related cardiovascular diseases. Chronic ERS activation via the IRE1α‐XBP1, ATF6, and PERK pathways drives vascular endothelial dysfunction (reduced NO bioavailability, increased ET‐1), renin‐angiotensin system (RAS) hyperactivation ...
Xin Ma   +6 more
wiley   +1 more source

Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood

open access: yesNeurology International
The number of published cases of presumed iatrogenic cerebral amyloid angiopathy (iCAA) due to the transmission of amyloid β during neurosurgery is slowly rising. One of the potential ways of transmission is through a cadaveric dura mater graft (LYODURA)
Maša Fabjan   +4 more
doaj   +1 more source

Complement in the pathogenesis of Alzheimer's disease [PDF]

open access: yes, 2017
The emergence of complement as an important player in normal brain development and pathological remodelling has come as a major surprise to most scientists working in neuroscience and almost all those working in complement.
A Alawieh   +87 more
core   +2 more sources

Diagnosis, treatment, and follow-up of patients with cerebral amyloid angiopathy-related inflammation [PDF]

open access: yes, 2022
Purpose Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare potentially reversible encephalopathy associated with an autoimmune process against proteins deposited in the walls of cortical and leptomeningeal brain vessels.
Battisti, Carla   +8 more
core   +2 more sources

Glymphatic and meningeal lymphatic dysfunction in Alzheimer's disease: Mechanisms and therapeutic perspectives

open access: yesAlzheimer's &Dementia, Volume 21, Issue 10, October 2025.
Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized by amyloid‐beta (Aβ) deposition and tau pathology. Although disease‐modifying therapies, such as anti‐Aβ monoclonal antibodies, have been approved, their clinical efficacy remains modest and accompanied by substantial safety concerns. The glymphatic system, which is a brain‐
Jiangwei Ding   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy